• News
  • New article published in "Platform Life Sciences" presenting ATRIVA approach

New paper published about anti-influenza activity of CI-1040

Our scientific founders published a new paper on antiviral action of MEK inhbitors in Antiviral Research, the highest-ranking journal in the area of antiviral therapy and the fourth-highest in the general field of virology.

The paper is entitled: "The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo."

You can download the paper here: Download

Address

Atriva Therapeutics GmbH
Christophstr. 32, 72072 Tübingen

+49 (0)7071 8597673
info@atriva-therapeutics.com